MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-02-0077581
Betlife Formulations Private Limited - chemicals in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.39 Cr
▼ 11% YoY
Net loss · FY 2025
₹3.14 Lakh
Net margin -2.3%
EBITDA · FY 2025
-₹3.13 Lakh
EBITDA margin -2.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Employees · EPFO
6
Provident fund records
Directors on board
3
As per MCA filings
About Betlife Formulations Private Limited
Data last updated:
Betlife Formulations Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 13 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U51909TN2016PTC029548. Its GSTIN is 36AAGCB7153E1ZS (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kathiravan Chinnusamy and Shivaramakrishna Prasad Pulluri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at # 154 7th Street Sakthi Nagar Ganesh Avenue Porur Triuvallur, Chennai, Tamil Nadu, India – 600116.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.39 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net loss of ₹3.14 Lakh (net margin -2.3%) and EBITDA of -₹3.13 Lakh (EBITDA margin -2.3%). Revenue has declined at a compounded annual rate (CAGR) of 13% over three years and 1% over five years.
The company has about 6 employees on its provident fund (EPFO) records.
Betlife Formulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0077581). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website betlife.in.
Company details
CIN U51909TN2016PTC029548
Registration Number 029548
Incorporation Date 13 May 2016
ROC Coimbatore
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TN-02-0077581
CIN history
Betlife Formulations has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U51909TN2016PTC029548, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51909TN2016PTC029548 | Current |
| U51909TG2016PTC109631 | Previous |
| U51909TZ2016PTC029548 | Previous |
Key People
Kathiravan Chinnusamy Director Shivaramakrishna Prasad Pulluri Director Krishnamoorthy Pradhip Kumar Director Recognitions & Rankings of Betlife Formulations
Contact details
Betlife Formulations Private Limited's registered office is in Chennai, Tamil Nadu. Its website is betlife.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address# 154 7th Street Sakthi Nagar Ganesh Avenue Porur Triuvallur, Chennai, Tamil Nadu, India – 600116
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Betlife Formulations Private Limited, buy the company report.
Comprehensive company report
Betlife Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Betlife Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Betlife Formulations Private Limited, buy the company report.
Financials of Betlife Formulations Private Limited
FY 2025 filings availableBetlife Formulations Private Limited reported revenue of ₹1.39 Cr (down 11% YoY) for FY 2025.
Revenue · FY 2025
₹1.39 Cr ▼ 11%
Net loss · FY 2025
₹3.14 Lakh margin -2.3%
EBITDA · FY 2025
-₹3.13 Lakh margin -2.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 11%
3 years · compounded
▼ 13%
5 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▼ 359%
3 years · compounded
▼ 28%
5 years · compounded
▼ 22%
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 11% fall in the latest year. EBITDA fell 359% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.13 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.14 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2.3% | ||||
| Net Profit Margin | -2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Betlife Formulations Private Limited, buy the company report.
Board of directors of Betlife Formulations Private Limited
Betlife Formulations has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kathiravan Chinnusamy Also directs: Q Check Pharmaceuticals Private Limited | Director | 13 Jan 2021 | 5 Years 10 Months | Current |
| Shivaramakrishna Prasad Pulluri | Director | 13 May 2016 | 10 Years 6 Months | Current |
| Krishnamoorthy Pradhip Kumar Also directs: Q Check Pharmaceuticals Private Limited | Director | 13 Jan 2021 | 5 Years 10 Months | Current |
Peer comparison
Betlife Formulations Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vibrant Pharmacuticals Private Limited | ₹1.39 Cr (FY 2025) | 16.0% | Vadodara, Gujarat, India | |||
| Astalon Pharma Private Limited | ₹1.39 Cr (FY 2016) | -40.0% | Chandigarh, India | |||
| Euro Formulations Private Limited | ₹1.39 Cr (FY 2016) | 20229.0% | Bhind, Madhya Pradesh, India | |||
| Betlife Formulations Private Limitedthis company | ₹1.39 Cr (FY 2025) | -₹3.14 Lakh | -2.3% | -11.0% | 6 | Chennai, Tamil Nadu, India |
| Vaishno Drugs & Intermediates Private Limited | ₹1.38 Cr (FY 2025) | 61.0% | Hyderabad, Telangana, India | |||
| Panorama Chempaint Private Limited | ₹1.38 Cr (FY 2024) | 4.0% | Allahabad, Uttar Pradesh, India | |||
| Minksun Agro Private Limited | ₹1.38 Cr (FY 2025) | 32.0% | Chandigarh, India |
To see the full peer comparison of Betlife Formulations Private Limited, buy the company report.
Auditor
Betlife Formulations Private Limited is audited by RAJSEKHARA & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJSEKHARA & ASSOCIATES | FY 2020 | 011714S |
Shareholding
The shareholding of Betlife Formulations Private Limited is on record for 2 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Betlife Formulations Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Betlife Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Betlife Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Betlife Formulations Private Limited has a workforce of 6 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
6
Active EPFO establishments
1
Employee growth
50%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 6 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 |
To see the full employee and EPFO history of Betlife Formulations Private Limited, buy the company report.
GST
Betlife Formulations has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCB7153E1ZS | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Betlife Formulations Private Limited, buy the company report.
Recent activity
Betlife Formulations Private Limited has 5 board changes on record since 2016: 3 appointments and 2 cessations. The latest: Kathiravan Chinnusamy was appointed as Director on 13 Jan 2021.
AGM
Betlife Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Betlife Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Coimbatore.
Appointed
Kathiravan Chinnusamy was appointed as Director.
Appointed
Krishnamoorthy Pradhip Kumar was appointed as Director.
Ceased
Ravva Rajesh ceased to be Director.
Ceased
Sunitha Ravva ceased to be Director.
Appointed
Shivaramakrishna Prasad Pulluri was appointed as Director.
Incorporation
13 May 2016
Betlife Formulations Private Limited was registered on 13 May 2016 with Roc Coimbatore & aged 10 years 6 months as per MCA records.
Frequently asked questions
Betlife Formulations is an active private limited company based in Chennai, Tamil Nadu, India. The company works in chemical products, within the chemicals industry. It was incorporated on 13 May 2016 (10+ years old) and is registered under CIN U51909TN2016PTC029548.
Betlife Formulations has 3 current directors:
- Kathiravan Chinnusamy - Director
- Shivaramakrishna Prasad Pulluri - Director
- Krishnamoorthy Pradhip Kumar - Director
The latest financial statements of Betlife Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Betlife Formulations is 36AAGCB7153E1ZS, registered in Telangana.
The CIN (Corporate Identification Number) of Betlife Formulations is U51909TN2016PTC029548. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Betlife Formulations was incorporated on 13 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Coimbatore.
The peers of Betlife Formulations by revenue are Vibrant Pharmacuticals Private Limited, Astalon Pharma Private Limited, Euro Formulations Private Limited, Vaishno Drugs & Intermediates Private Limited, Panorama Chempaint Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kathiravan Chinnusamy was appointed as Director on 13 Jan 2021. Krishnamoorthy Pradhip Kumar was appointed as Director on 13 Jan 2021. Ravva Rajesh ceased to be Director on 13 Jan 2021. Betlife Formulations has 5 board changes on record in total.
Yes, Betlife Formulations is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0077581).
Betlife Formulations can be reached through the website betlife.in. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Betlife Formulations is at # 154 7th Street Sakthi Nagar Ganesh Avenue Porur Triuvallur, Chennai, Tamil Nadu, India – 600116.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages